Work

Abstract CT031: COM701 demonstrates preliminary antitumor activity as monotherapy and in combination with nivolumab in patients with advanced solid tumors

Year: 2020

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2020-ct031

Authors: Ryan Sullivan, Drew Rasco, Emerson Lim, Manish Sharma, Dale Shepard, Amita Patnaik, Erika Hamilton, Gini Fleming, Kyri Papadopoulos, Adam ElNaggar, Adeboye Henry Adewoye, Bartosz Chmielowski, Ecaterina Dumbrava, Dan Vaena

Institutions: Harvard University, Massachusetts General Hospital, South Texas Accelerated Research Therapeutics, Herbert Irving Comprehensive Cancer Center, Cleveland Clinic, Tennessee Oncology, University of Chicago, Annexon Biosciences (United States), Instacart (United States), University of California, Los Angeles, The University of Texas MD Anderson Cancer Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3083632537

Cites:

Cited by: 8

Related to: 10